New updated to:
0

New updated to:
0

CPT Code updated to:
87181 x2

CPT Code updated to:
87181 x 3

Acceptable updated to:
Nasopharyngeal or tracheal lavage/wash; eye, nasopharyngeal or throat swab in M4 or V-C-M medium
Bone marrow ( ACD or EDTA)

Acceptable updated to:
Whole blood (EDTA , ACD), serum, CSF, bronchial, nasopharyngeal or tracheal lavage/wash, sputum, urine, eye swab in M4 or V-C-M medium
Bone marrow ( ACD or EDTA), tissue or stool

Acceptable updated to:
Sputum, bronchial lavage/wash, plasma (ACD, EDTA), whole blood (ACD, EDTA), serum (no additive red-top or SST), CSF or urine
Bone marrow ( ACD or EDTA)

newseq updated to:
0.0

Preferred Specimen updated to:
3 mL throat or nasopharyngeal swabs in M4 media or V-C-M media (green-cap) tube or equivalent (UTM) medium (green-cap) tube or equivalent (UTM) or multimicrobe media (M4)
(minimum 0.35 mL)
Use only sterile swabs: Dacron, nylon, or rayon with plastic shafts. DO NOT USE calcium alginate swabs.
Throat swab is no longer acceptable.

New updated to:
0

New updated to:
0

New updated to:
0

New updated to:
0

Description updated to:
Susceptibility testing is performed by a broth microdilution method that includes: Amikacin, Ciprofloxacin, Clarithromycin, Ethambutol, Ethionamide, Isoniazid, Linezolid, Moxifloxacin, Rifampin, Rifabutin, Streptomycin.

Drug Combinations are tested using Agar proportion: Ethambutol plus different concentrations of Clarithromycin, Erythromycin, Rifampin, or Rifabutin.

Linezolid and moxifloxacin will be tested with results released only for isolates non-susceptible to clarithromycin.

Clarithromycin is the only antimicrobial for which CLSI interpretive guidelines are established.

Identification of the isolate is required.

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL CSF; 3 mm biopsy or equivalent piece of tissue from brain, lung, cornea or lesions; Corneal scrapings from affected area; 1 swab of conjunctiva/corneal ulcer; both contact lenses or lens care solution from an open container already in use by patient.

Reference Range updated to:
Not Isolated

Title updated to:
Acanthamoeba/Naegleria Culture

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL CSF; 3 mm biopsy or equivalent piece of tissue from brain, lung, cornea or lesions; Corneal scrapings from affected area; 1 swab of conjunctiva/corneal ulcer; both contact lenses or lens care solution from an open container already in use by patient.

Reference Range updated to:
Not Detected

Title updated to:
Acanthamoeba/Naegleria Direct Detection, FM

Preferred Specimen updated to:
1 mL synovial fluid
(minimum 1 mL)
Please note: All other fluids are unacceptable

Title updated to:
Rheumatoid Factor, LA, Synovial Fluid

newseq updated to:
0.0

Preferred Specimen updated to:
2g or 2 mL stool
(1g or 1 mL minimum)
Acceptable container types:
10% formalin, MF, SAF or equivalent fixative C&S transport medium (Cary-Blair or equivalent) Fresh, untreated stool submit in sterile container

Reference Range updated to:
Not Detected

Title updated to:
Cryptosporidium Antigen, EIA

Transport Temperature updated to:
Fixative and Cary-Blair:
Room temperature

Fresh stool:
FROZEN

newseq updated to:
0.0

Preferred Specimen updated to:
10g stool
(5g minimum)
Acceptable container types:
10% formalin, MF, SAF or equivalent fixative C&S transport medium (Cary-Blair or equivalent) Fresh, untreated stool submit in sterile container

Title updated to:
Giardia Antigen, EIA, Stool

Transport Temperature updated to:
Fixative:
Room temperature

Cary-Blair:
Refrigerated

Fresh stool:
Frozen

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL CSF
(minimum 0.7 mL)

newseq updated to:
0.0

New updated to:
0

New updated to:
0

New updated to:
0

New updated to:
0

New updated to:
0

New updated to:
0

Reference Range updated to:
PT IgG <45 IU/mL
PT IgA <10 IU/mL
FHA IgG <90 IU/mL
FHA IgA <50 IU/mL

Transport Temperature updated to:
Room temperature

newseq updated to:
0.0

Reference Range updated to:
PT IgG <45 IU/mL
FHA IgG <90 IU/mL

Transport Temperature updated to:
Room temperature

newseq updated to:
0.0

Preferred Specimen updated to:
0.2 mL serum
(minimum 0.1 mL)

Reference Range updated to:
Negative

Transport Temperature updated to:
Room temperature

newseq updated to:
0.0

Results Available updated to:
24 hours

Results Available updated to:
24 hours

Results Available updated to:
24 hours

Results Available updated to:
24 hours

New updated to:
0

Results Available updated to:
24 hours

Results Available updated to:
24 hours

New updated to:
0

Results Available updated to:
24 hours

Results Available updated to:
24 hours

Results Available updated to:
24 hours

Results Available updated to:
24 hours

Results Available updated to:
24 hours

New updated to:
0

New updated to:
0

New updated to:
0

Results Available updated to:
24 hours

Results Available updated to:
24 hours

Results Available updated to:
24 hours

New updated to:
0

Discontinued updated to:
15510

newseq updated to:
0.0

Reference Range updated to:
<0.1 mcg/mL

Title updated to:
Acyclovir, HPLC

newseq updated to:
0.0

Reference Range updated to:
< 0.1 mcg/mL

Title updated to:
Amprenavir, HPLC

newseq updated to:
0.0

Reference Range updated to:
< 1.0 mcg/mL

Title updated to:
Capreomycin, HPLC

newseq updated to:
0.0

Reference Range updated to:
< 1.0 mcg/mL

Title updated to:
Fluconazole, HPLC

newseq updated to:
0.0

Reference Range updated to:
< 0.1 mcg/mL

Title updated to:
Ganciclovir, HPLC

newseq updated to:
0.0

Reference Range updated to:
< 0.2 mcg/mL

Title updated to:
Indinavir, HPLC

newseq updated to:
0.0

Reference Range updated to:
< 0.2 mcg/mL

Title updated to:
Kaletra™, HPLC

newseq updated to:
0.0

Reference Range updated to:
< 0.1 mcg/mL

Title updated to:
Nelfinavir, HPLC

newseq updated to:
0.0

Reference Range updated to:
< 0.1 mcg/mL

Title updated to:
Nevirapine, HPLC

newseq updated to:
0.0

Reference Range updated to:
< 0.1 mcg/mL

Title updated to:
Saquinavir, HPLC

newseq updated to:
0.0

Reference Range updated to:
< 1.0 mcg/mL

Title updated to:
Streptomycin, HPLC

newseq updated to:
0.0

Title updated to:
Sulfamethoxazole, HPLC

newseq updated to:
0.0

Discontinued updated to:
15564

Title updated to:
Lyme Disease (B burgdorferi) QL DNA Real-Time PCR, CSF or Synovial Fluid

newseq updated to:
0.0

Discontinued updated to:
15777

newseq updated to:
0.0

Discontinued updated to:
15868

newseq updated to:
0.0

Reference Range updated to:
<15 nmol/L

newseq updated to:
0.0

Description updated to:
Blood smears are prepared (both thick and thin), stained, and examined for detection of malaria parasites, Babesia, trypanosomes, and microfilaria or tissue specimen slide preparations (touch preps) are stained and examined microscopically for the presence of Leishmania and Toxoplasma. Client prepared slides are preferred.

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

Preferred Specimen updated to:
0.5 g
OR
1 mL Stool in 10% formalin, SAF or equivalent

Preferred Specimen updated to:
1 mL CSF
(minimum 0.2 mL)

Preferred Specimen updated to:
1 mL serum
(minimum 0.25 mL)

Preferred Specimen updated to:
5 mL or 5 grams stool in a clean sterile container (no preservative).
(minimum 2 mL or 2 grams)

Reference Range updated to:
Not detected

Transport Temperature updated to:
FROZEN at <= -60 degrees centigrade on dry ice (preferred)

newseq updated to:
0.0

Title updated to:
Herpesvirus 8 (HHV-8) DNA, Qual to Quant Real-Time PCR Reflex

newseq updated to:
0.0

Title updated to:
Herpesvirus 8 (HHV-8) DNA, Qualitative Real-Time PCR

newseq updated to:
0.0

Title updated to:
Herpesvirus 8 (HHV-8) DNA, Quantitative Real-Time PCR

newseq updated to:
0.0

Title updated to:
Respiratory Syncytial Virus (RSV) RNA, Qualitative Real-Time PCR

Description updated to:
The fluorescent stain is used for the rapid detection of Acanthamoeba and Naegleria cysts. For detection of intestinal amebae, such as Entamoeba histolytica, please request Focus unit code 51730, Parasite Examination (Ova and Parasite).

newseq updated to:
0.0

Transport Temperature updated to:
Whole blood: Room temperature
All others: FROZEN

newseq updated to:
0.0

Preferred Specimen updated to:
0.7 mL plasma (EDTA or ACD) or serum CSF and urine are unacceptable for this test code
(minimum 0.3 mL)

Transport Temperature updated to:
FROZEN

Preferred Specimen updated to:
0.7 mL EDTA (lavender-top) plasma
(minimum 0.3 mL)

Preferred Specimen updated to:
0.7 mL EDTA (lavender-top) plasma
(minimum 0.3 mL)

Title updated to:
BK Virus DNA, Quantitative Real-Time PCR, Urine

Acceptable updated to:
Vaginal swab in Aptima Vaginal Swab Collection kit.

Acceptable updated to:
Serum, urine, plasma (EDTA, ACD, or PPT), whole blood (EDTA, ACD); pleural, pericardial, amniotic or vitreous fluid in sterile leak-proof container; 3 mm³ tissue
Vaginal swab in Aptima Vaginal Swab Collection kit.

Acceptable updated to:
1 mL serum, plasma (EDTA, ACD) CSD or amniotic fluid
(minimum 0.3 mL)

Preferred Specimen updated to:
0.7 mL plasma (EDTA, ACD) or serum
(minimum 0.3 mL)

Preferred Specimen updated to:
0.7 mL plasma (EDTA, ACD) or serum
(minimum 0.3 mL)

NYSDOH updated to:
Y

NYSDOH updated to:
Y

Transport Temperature updated to:
Whole blood and CSF: Refrigerated
Tissue: FROZEN

newseq updated to:
0.0

Methodology updated to:
Immunoblot

Title updated to:
Helicobacter pylori Antibodies (IgG, IgA), Immunoblot

newseq updated to:
0.0

Methodology updated to:
Immunoblot

Title updated to:
Helicobacter pylori Antibody (IgA), Immunoblot

newseq updated to:
0.0

Methodology updated to:
Immunoblot

Title updated to:
Helicobacter pylori Antibody (IgG), Immunoblot

newseq updated to:
0.0

CPT Code updated to:
87502

newseq updated to:
0.0

Preferred Specimen updated to:
Pure culture of anaerobic isolate on a slant, plate or swab Swabs transport in an appropriate Amies agar gel transport medium (or equivalent)

Title updated to:
Susceptibility Panel, Anaerobic Bacteria, MIC (Gradient)

Transport Temperature updated to:
Refrigerated (2-8° C)
(preferred and may help improve isolate viability)

newseq updated to:
0.0

Description updated to:
The following antimicrobials are available for susceptibility testing. To inquire about additional drugs, contact Client Services.

Antibacterial Amikacin Amoxicillin Amoxicillin/   Clavulanate Ampicillin Ampicillin/   Sulbactam Azithromycin Aztreonam Bacitracin Carbenicillin Cefaclor Cefazolin Cefepime Cefixime Cefotaxime Ceftazidime Cefoxitin Cefpodoxime Cefprozil Ceftriaxone Cefuroxime Cephalexin Cephalothin Chloramphenicol Ciprofloxacin Clarithromycin Clindamycin Colistin

Daptomycin Dicloxacillin Doripenem Doxycycline Ertapenem Erythromycin Gentamicin Imipenem Kanamycin Levofloxacin Linezolid Meropenem Metronidazole Minocycline Moxifloxacin Mupirocin Nafcillin Nalidixic Acid Neomycin Nitrofurantoin Ofloxacin Oxacillin Penicillin Pipercillin Pipercillin/   Tazobactam Polymyxin B Quinupristin/   Dalfopristin

Rifampin Streptomycin Sulfamethoxazole Sulfisoxazole Tetracycline Ticarcillin Ticarcillin/   Clavulanate Tigecycline Tobramycin Trimethoprim Trimethoprim/   Sulfamethoxazole Vancomycin Antifungal Amphotericin B Anidulafungin Butoconazole Caspofungin Clotrimazole Fluconazole 5-Fluorocytosine Griseofulvin Itraconazole Ketoconazole Micafungin Miconazole Natamycin Nystatin Terbinafine Terconazole Voriconazole

Antimycobacterial Amikacin Capreomycin Cefoxitin Ciprofloxacin Clarithromycin Cycloserine Doxycycline Ethambutol Ethionamide Imipenem Isoniazid Kanamycin Linezolid Minocycline Moxifloxacin p-Aminosalicylic acid Pyrazinamide Rifabutin Rifampicin Rifampin Streptomycin Tigecycline Tobramycin Trimethoprim/   Sulfamethoxazole Antiviral Acyclovir Foscarnet Ganciclovir

newseq updated to:
0.0

Discontinued updated to:
90342

newseq updated to:
0.0

NYSDOH updated to:
A

newseq updated to:
0.0

Title updated to:
Lymphocytic Choriomeningitis Virus AB, IFA (Serum)

newseq updated to:
0.0

New updated to:
0

New updated to:
0

newseq updated to:
0.0

Methodology updated to:
Antibody Neutralization

Preferred Specimen updated to:
2 mL serum
(minimum 1 mL)

Reference Range updated to:
< or = 1:2 titer

Title updated to:
Clost. difficile Cytotoxin Antibody, Neutralization

Transport Temperature updated to:
Refrigerated (2-8° C)

newseq updated to:
0.0

Acceptable updated to:
Add vaginal swab as an acceptable specimen type. Submit in Aptima Vaginal Swab Collection Kit.

Acceptable updated to:
Serum, urine, plasma (EDTA, ACD, or PPT), whole blood (EDTA, ACD); pleural, pericardial, amniotic or vitreous fluid in sterile leak-proof container; 3 mm³ tissue
Add vaginal swab as an acceptable specimen type. Submit in Aptima Vaginal Swab Collection Kit.

Preferred Specimen updated to:
1.0 mL serum
(minimum 0.2 mL)

newseq updated to:
0.0

Preferred Specimen updated to:
Nasal swab, Nasopharyngeal swab, Nasal aspirate or throat swab in Multi Microbe Media (M4) or V-C-M medium (green-cap) tube or equivalent (UTM).

Swabs must be sterile Dacron, nylon, or rayon with plastic shafts. Place swab in sterile viral transport media containing protein stabilizer, antibiotics to inhibit bacterial fungal growth, and buffer solution (e.g. UTM, VCM, M4, M5, M6 and other media intended to transport chlamydia, mycoplasma or viruses).

Preferred Specimen updated to:
Nasal swab, Nasopharyngeal swab, Nasal aspirate or throat swab in Multi Microbe Media (M4) or V-C-M medium (green-cap) tube or equivalent (UTM).

Swabs must be sterile Dacron, nylon, or rayon with plastic shafts. Place swab in sterile viral transport media containing protein stabilizer, antibiotics to inhibit bacterial fungal growth, and buffer solution (e.g. UTM, VCM, M4, M5, M6 and other media intended to transport chlamydia, mycoplasma or viruses).

Methodology updated to:
Kinetic

newseq updated to:
0.0

Title updated to:
Cytomegalovirus DNA, Qual to Quant Real-Time PCR Reflex

Title updated to:
Cytomegalovirus DNA, Qualitative Real-Time PCR

Title updated to:
Cytomegalovirus DNA, Quantitative Real-Time PCR

Acceptable updated to:
Lung tissue, sterile body fluids (pleural fluid, pericardial fluid or others)
Submit in a sterile container, do not add transport medium. Add minimal sterile saline to tissue to prevent drying.

Preferred Specimen updated to:
3 mL (1mL minimum) sputum, bronchial washings, tracheal aspirate, bronchoalveolar lavage, nasopharyngeal aspirate, respiratory fluid, 1 throat swab or 1 nasopharyngeal swab. Submit specimens in UTM, M4, M5 or equivalent.

Transport Temperature updated to:
Refrigerated: tissue and sterile fluid
Frozen < or = to -70 degrees centigrade: all other sample types

newseq updated to:
0.0

Title updated to:
Varicella-Zoster Virus AB (Immunity Screen), ACIF (Serum)

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

newseq updated to:
0.0

Title updated to:
Atypical pneumonia DNA Panel, Qualitative Real-Time PCR

newseq updated to:
0.0

Acceptable updated to:
0.85 mL bronchial lavage/wash, nasopharyngeal lavage/wash, tracheal lavage/wash or sputum in a sterile leak-proof container

Preferred Specimen updated to:
0.50 mL serum
(minimum 0.3 mL)

Title updated to:
Measles (Rubeola) IgG AB, IFA (CSF)

newseq updated to:
0.0

NYSDOH updated to:
Y

newseq updated to:
0.0

NYSDOH updated to:
Y

newseq updated to:
0.0

NYSDOH updated to:
Y

Title updated to:
Varicella-Zoster Virus (VZV) Antibody (Total, IgM), ACIF/IFA, CSF

newseq updated to:
0.0

Description updated to:
A positive VZV total antibody titer indicates a history of VZV infection or vaccination. In infected individuals, this test is usually positive within 2 days after the onset of rash and is thereafter positive for life. The absence of detectable antibody may indicate susceptibility to VZV infection.

The detection of VZV IgM usually indicates recent/current infection but occasionally may indicate reactivation of VZV or infection with other Herpes viruses. Definitive evidence for recent exposure to VZV would be detection of increasing total antibody titers between acute and convalescent sera.

NYSDOH updated to:
Y

Title updated to:
Varicella-Zoster Virus (VZV) Antibody (Total, IgM), ACIF/IFA, Serum

newseq updated to:
0.0

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

NYSDOH updated to:
A

Preferred Specimen updated to:
1 mL whole blood (EDTA, ACD), plasma (EDTA, ACD, PPT), CSF, serum, amniotic fluid, or urine
Minimum : 0.05 mL -CSF;
0.3 mL - all other specimen sources

New updated to:
0

New updated to:
0

Preferred Specimen updated to:
1 mL CSF in a sterile leak proof container; swab in M4 or
V-C-M medium
Minimum : 0.05 mL -CSF and vitreous fluid;
0.3 mL - all other specimen sources

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL amniotic fluid, CSF or tissue, serum, vitreous fluid, whole blood (EDTA or ACD), plasma (EDTA, ACD), bone marrow or buffy coat
Minimum: 0.05 mL -CSF and vitreous fluid;
0.3 mL - all other specimen sources

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL CSF, or whole blood (EDTA or ACD)
Minimum : 0.05 mL -CSF and eye fluid;
0.3 mL - all other specimen sources.

newseq updated to:
0.0

Preferred Specimen updated to:
Throat swab or nasopharyngeal swab in 3 mL
(minimum 0.35 mL)
M4 media or V-C-M medium (green-cap) tube or equivalent (UTM)

newseq updated to:
0.0

New updated to:
0

New updated to:
0

New updated to:
0

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
N

NYSDOH updated to:
N

NYSDOH updated to:
N

NYSDOH updated to:
N

NYSDOH updated to:
Y

NYSDOH updated to:
N

NYSDOH updated to:
N

New updated to:
0

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
N

NYSDOH updated to:
N

NYSDOH updated to:
N

NYSDOH updated to:
N

NYSDOH updated to:
N

NYSDOH updated to:
N

NYSDOH updated to:
N

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
N

NYSDOH updated to:
A

NYSDOH updated to:
N

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
A

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
Y

NYSDOH updated to:
A

NYSDOH updated to:
Y

Discontinued updated to:
6092

newseq updated to:
0.0

Discontinued updated to:
4094 with 40927

newseq updated to:
0.0

Description updated to:
See individual assay for description.

Panel includes:

• BK Virus DNA, Quantitative Real-Time PCR, Plasma
• JC Virus DNA Quantitative Real-Time PCR

Preferred Specimen updated to:
0.7 mL EDTA (lavender-top) plasma CSF and urine are unacceptable for this test code
(minimum 0.3 mL)

Title updated to:
BK and JC Virus DNA, Quantitative Real-Time PCR, Plasma

newseq updated to:
0.0

Discontinued updated to:
for plasma use 47900, for CSF use 18901, for urine use 47901

Preferred Specimen updated to:
0.7 mL EDTA (lavender-top) plasma CSF and urine are unacceptable for this test code.
(minimum 0.3 mL)

Title updated to:
BK Virus DNA, Qualitative Real-Time PCR, Plasma

Preferred Specimen updated to:
0.7 mL EDTA (lavender-top) plasma CSF and urine are unacceptable for this test code.
(minimum 0.3 mL)

Title updated to:
BK Virus DNA, Quantitative Real-Time PCR, Plasma

Preferred Specimen updated to:
0.7 mL EDTA (lavender-top) plasma CSF and urine are unacceptable for this test code.
(minimum 0.3 mL)

Title updated to:
JC Polyoma Virus DNA, Qualitative Real-Time PCR, Plasma

newseq updated to:
0.0

Preferred Specimen updated to:
0.7 mL EDTA (lavender-top) plasma CSF and urine are unacceptable for this test code.
(minimum 0.3 mL)

Title updated to:
JC Polyoma Virus DNA, Quantitative Real-Time PCR, Plasma

newseq updated to:
0.0

newseq updated to:
0.0

Discontinued updated to:
60555

newseq updated to:
0.0

Description updated to:
See individual assay for description.

Panel Includes:

• Herpes Simplex Virus (HSV) 1/2 IgM Panel, IFA
• Herpes Simplex Virus 1/2 (IgG) Type-specific Antibodies, CSF

newseq updated to:
0.0

Discontinued updated to:
60335, 60435, 60555, 60545, 60625, 60712

newseq updated to:
0.0

newseq updated to:
0.0

Discontinued updated to:
6031

newseq updated to:
0.0

Discontinued updated to:
60923, 60924, 64600, 64605, 60555, 60545, 60880, 60885

newseq updated to:
0.0

Discontinued updated to:
60923, 64600, 60555, 60880

newseq updated to:
0.0

newseq updated to:
0.0

Results Available updated to:
1 to 5 days

newseq updated to:
0.0

Results Available updated to:
1 to 5 days

newseq updated to:
0.0

Results Available updated to:
1 to 5 days

newseq updated to:
0.0

Results Available updated to:
1 to 5 days

newseq updated to:
0.0

Reference Range updated to:
Negative

Reference Range updated to:
Negative

Reference Range updated to:
Negative

Transport Temperature updated to:
Room temperature

newseq updated to:
0.0

CPT Code updated to:
86694; 86695; 86696 (Add 86694 if confirmed)

Preferred Specimen updated to:
1 mL Serum
(minimum 0.2 mL)

Reference Range updated to:
Negative

Title updated to:
Helicobacter pylori Antibody (IgA), EIA

Transport Temperature updated to:
Room temperature

newseq updated to:
0.0

Description updated to:
Gastric colonization by Helicobacter pylori has been implicated as a cofactor in the development of some cases of gastritis and peptic or duodenal ulcer. Gastroduodenal disease caused by H. pylori can be successfully treated with antimicrobial therapy. Eradication of H. pylori infection has been associated with decreasing IgG and IgA antibody levels to H. pylori. As IgG levels to H. pylori are encountered in a large percentage of adults, clinicians should be aware that age-related acquisition of H. pylori contributes to the age-related increase in the incidence of H. pylori antibody. Measurement of antibodies to H. pylori is not recommended for the diagnosis of active infection. The American College of Gastroenterology and the American Gastroenterological Association recommend either the urea breath test or the fecal antigen test for diagnosis and confirmation of eradication in cases of suspected or proven H. pylori infection.

Methodology updated to:
EIA (Enzyme Immunoassay)

Preferred Specimen updated to:
1 mL Serum
(minimum 0.2 mL)

Reference Range updated to:
Negative

Title updated to:
Helicobacter pylori Antibody (IgG), EIA

Transport Temperature updated to:
Room temperature

newseq updated to:
0.0

Description updated to:
Gastric colonization by Helicobacter pylori has been implicated as a cofactor in the development of some cases of gastritis and peptic or duodenal ulcer. Gastroduodenal disease caused by H. pylori can be successfully treated with antimicrobial therapy. The clinical utility of H. pylori IgM antibody measurement has not been clearly established. H. pylori IgM testing may result in false positives. To identify active H. pylori infection, a urea breath test or stool antigen test should be considered if clinically indicated.

Methodology updated to:
EIA (Enzyme Immunoassay)

Preferred Specimen updated to:
1 mL Serum
(minimum 0.2 mL)

Reference Range updated to:
Negative

Title updated to:
Helicobacter pylori Antibody (IgM)

Transport Temperature updated to:
Room temperature

newseq updated to:
0.0

Discontinued updated to:
40186

newseq updated to:
0.0

Discontinued updated to:
40324

newseq updated to:
0.0

Discontinued updated to:
40187

newseq updated to:
0.0

Reference Range updated to:
<20 copies/mL;
<1.30 Log copies/mL

New updated to:
0

NYSDOH updated to:
A

newseq updated to:
0.0

NYSDOH updated to:
Y

Reference Range updated to:
<=5.0 mcg/mL

newseq updated to:
0.0

Description updated to:
Specimens collected just before or within 15 minutes of the next antibiotic dose represent the TROUGH levels. Specimens obtained within 15-30 minutes after the end of I.V. infusion or 45-60 minutes after an IM injection or 90 minutes after oral intake represent the PEAK level.

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

newseq updated to:
0.0

Description updated to:
Specimens collected just before or within 15 minutes of the next antibiotic dose represent the TROUGH levels. Specimens obtained within 15-30 minutes after the end of I.V. infusion or 45-60 minutes after an IM injection or 90 minutes after oral intake represent the PEAK level.

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

newseq updated to:
0.0

Description updated to:
Specimens collected just before or within 15 minutes of the next antibiotic dose represent the TROUGH levels. Specimens obtained within 15-30 minutes after the end of I.V. infusion or 45-60 minutes after an IM injection or 90 minutes after oral intake represent the PEAK level.

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

newseq updated to:
0.0

Description updated to:
Specimens collected just before or within 15 minutes of the next antibiotic dose represent the TROUGH levels. Specimens obtained within 15-30 minutes after the end of I.V. infusion or 45-60 minutes after an IM injection or 90 minutes after oral intake represent the PEAK level.

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

newseq updated to:
0.0

Description updated to:
Specimens collected just before or within 15 minutes of the next antibiotic dose represent the TROUGH levels. Specimens obtained within 15-30 minutes after the end of I.V. infusion or 45-60 minutes after an IM injection or 90 minutes after oral intake represent the PEAK level.

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

Title updated to:
Dicloxacillin Level, BA

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.5 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.5 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

Transport Temperature updated to:
FROZEN at <=-70° C

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.5 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=5.0 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.5 mcg/mL

Results Available updated to:
3 to 4 days

Preferred Specimen updated to:
1 mL serum, CSF or other body fluid
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=1.0 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.1 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=5.0 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=0.5 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
<=5.0 mcg/mL

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum
(minimum 0.5 mL)
Serum separator tubes and all other fluids are unacceptable.

Reference Range updated to:
Trimethoprim: <=0.1 mcg/mL
Sulfamethoxazole: <=1.0 mcg/mL

Title updated to:
Trimeth/Sulfa Level, BA

newseq updated to:
0.0

Preferred Specimen updated to:
1 mL serum poured off into a cryogenic vial (i.e., DNAse, RNAse, pyrogen free). Glass tubes are unacceptable. Draw blood in plain red-top tube or SST, then pour off into a cryogenic vial.
Grossly hemolyzed, lipemic, or colored serum is unacceptable for testing.

NYSDOH updated to:
Y

NYSDOH updated to:
Y